ANN L. LEE

Insider Reports History

Location
Seattle, WA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANN L. LEE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Chief Technical Officer Common Stock 100,000 $112,999 $1.13 21 May 2025 Direct
Prime Medicine, Inc. Chief Technical Officer Stock Option (right to buy) 375,000 23 Feb 2026 Direct

Insider Reports Filed by ANN L. LEE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 23 Feb 2026 1 $0 4 Chief Technical Officer 24 Feb 2026, 17:07
PRME Prime Medicine, Inc. 01 Aug 2025 4 $0 4 Chief Technical Officer 05 Aug 2025, 20:44
PRME Prime Medicine, Inc. 21 May 2025 1 +$113,000 4 Chief Technical Officer 22 May 2025, 16:21
PRME Prime Medicine, Inc. 08 May 2025 1 $0 4 Chief Technical Officer 12 May 2025, 16:48
PRME Prime Medicine, Inc. 27 Feb 2025 1 $0 4 Chief Technical Officer 03 Mar 2025, 20:14
PRME Prime Medicine, Inc. 17 May 2024 1 $0 4 Chief Technical Officer 21 May 2024, 16:10
PRME Prime Medicine, Inc. 21 Feb 2024 1 $0 4 Chief Technical Officer 23 Feb 2024, 17:02
PRME Prime Medicine, Inc. 31 Mar 2023 1 $0 4 Chief Technical Officer 04 Apr 2023, 20:22
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 Chief Technical Officer 19 Oct 2022, 20:07